Ignite Creation Date:
2025-12-25 @ 2:10 AM
Ignite Modification Date:
2025-12-26 @ 12:38 AM
Study NCT ID:
NCT00258960
Status:
COMPLETED
Last Update Posted:
2023-04-04
First Post:
2005-11-24
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Caelyx, Cyclophosphamide and Herceptin in Patients With Metastatic Breast Cancer
Sponsor:
Spanish Breast Cancer Research Group
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-02-15
Start Date Type:
ACTUAL
Primary Completion Date:
2008-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-07-14
Completion Date Type:
ACTUAL
First Submit Date:
2005-11-24
First Submit QC Date:
None
Study First Post Date:
2005-11-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-01-25
Results First Submit QC Date:
None
Results First Post Date:
2019-07-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-03
Last Update Post Date:
2023-04-04
Last Update Post Date Type:
ACTUAL